Association between serum level soluble programmed cell death ligand 1 and prognosis in patients with non‐small cell lung cancer treated with anti‐PD‐1 antibody

BACKGROUND: Programmed cell death ligand 1 (PD‐L1) is known to have soluble forms aside from its membrane‐bound forms. The aim of this study was to evaluate the predictive and prognostic values of serum soluble PD‐L1 (sPD‐L1) in patients with non‐small cell lung cancer (NSCLC) who were treated with...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Thorac Cancer
Päätekijät: Murakami, Shuji, Shibaki, Ryota, Matsumoto, Yuji, Yoshida, Tatsuya, Goto, Yasushi, Kanda, Shintaro, Horinouchi, Hidehito, Fujiwara, Yutaka, Yamamoto, Noboru, Ohe, Yuichiro
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: John Wiley & Sons Australia, Ltd 2020
Aiheet:
Original Articles
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7705908/
https://ncbi.nlm.nih.gov/pubmed/33108686
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.13721
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia